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DESENSITIZATION OF 
MYOCARDIAL 
ADRENERGIC R~ECEPTORS 
AND DETERIORATION OF 
LEFT VENTRICULAR 
FUNCTION AFTER 8FIAIN 
DEATH 
Brain death offen results in a series of hemodynamic alterations that 
complicate the treatment of potential organ donors before transplantation. 
The deterioration of myocardial performance after brain death has been 
described; however, the pathophysiologie process of the myoeardial dys- 
function that occurs after brain death has not been elucidated. This study 
was designed to analyze the function of the myocardial l]-adrenergic 
receptor and the development of left ventricular dysfunetion in a porcine 
model of experimental brain death. Analysis of the 13-receptor included 
determination of receptor density and adenylate cyclase activity after 
stimulation independently at the receptor protein, the G protein, and the 
adenylate cyclase moiety. Myoeardial ~-reeeptor density did not change 
after the induction of brain death. A deerease in stimulated adenylate 
cyclase activity was observed within the frst hour after brain death at the 
level of the JB-receptor, the G protein, and the adenylate cyclase moiety, 
which suggests the oceurrence of rapid desensitization of I]-receptor 
funetion. Significant deterioration of myocardial performance also oceurred 
within the first hour after brain death, represented by a decrease in preload- 
recruitable stroke work compared with the baseline value. The deteriora- 
tion of myoeardial performance after brain death correlates temporally 
with desensitization of the myoeardial iß-receptor signal transduction 
system. The mechanism of impairment appears to be localized to the 
adenylate cyclase moiety itself. (J THORAC CARDIOVASC SURG 1995;110: 
746-51) 
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T he success of transplantation is contingent on adequate organ availability and the treatment 
of brain-dead organ donors. Brain death is offen 
accompanied by hemodynamic instability and im- 
paired cardiac function, as found both in experimen- 
tal animals and in potential organ donors. Hemody- 
namic compromise after brain death threatens the 
viability of all of the organs in a potential donor, and 
optimal preservation of cardiac function would pro- 
tect these organs for retrieval. 
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Alterations in preload and afterload may contrib- 
ute to the hemodynamic instability that occurs after 
irreversible cerebral ischemia; however, recent stud- 
ies demonstrate that brain death produces de- 
creased myocardial contractility independently. 1-3
Numerous experimental models have been used to 
investigate the pathophysiologic process of brain 
death and myocardial dysfunction. The induction of 
brain death in experimental nimals has been shown 
to induce autonomic storm, with significant eleva- 
tion of serum concentrations of epinephrine and 
norepinephrine. 4 This massive release of endoge- 
nous catecholamines produces calcium overflow in- 
jury to the myocardium, which results in contraction 
band neerosis, myocytolysis, and impaired contrac- 
tile mechanisms in the myocyte. 5'6 Furthermore, the 
deterioration of myocardial performance after brain 
death has been quantified by the use of preload- 
recruitable stroke work, a load-independent i dex of 
left ventricular performance. 1 Several investigators 
have demonstrated that the hemodynamic alter- 
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ations that follow brain death may be prevented by 
the administration of propranolol before the induc- 
tion of cerebral ischemia, 7's which implicates the 
/3-adrenergic signal transduction pathway in the 
pathophysio][ogic process of impaired myocardial 
performance after brain death. However, direct 
function of the /3-adrenergic receptor during cere- 
bral ischemia nd its direct role in the development 
of left ventricular dysfunction after the induction of 
brain death have not been investigated. 
The diversity of the components involved in the 
membrane ¢3-receptor complex, that is, the/3-recep- 
tor protein, the guanine nucleotide binding regula- 
tory protein (G protein), and the effector (the 
adenylate cyclase moiety), is depicted in Fig. 1. 
When a /3-agonist, such as isoproterenol, binds to 
the receptor, the intermediary G protein (Gs) trans- 
duces the signal to the effector system (the adenylate 
cyclase moiety), which is coupled to production of a 
second messenger, cyclic adenosine monophosphate 
(cAMP). G protein function requires the hydrolysis 
of guanosine 5'-triphosphate (GTP) and may also 
be stimulated independently by sodium fluoride at 
another site. The activated form of the G protein is 
coupled to the adenylate cyclase moiety, which itself 
may be activated independently by forskolin. 
This study attempted to describe the mechanism 
of the deterioration of myocardial performance in a 
porcine model of experimental brain death with use 
of a functional analysis of the/3-receptor complex, 
including density and adenylate cyclase stimulation 
at the level of the/3-receptor p otein, the G protein, 
and the adenylate cyclase moiety. 
Methods 
All animals reeeived humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the National Aeademy of Seiences (NIH 
Publication No. 86-23, revised 1985). This study used a 
validated poreine model of brain deathJ' 9 After institu- 
tional animal care eommittee approval, 12 pigs (30 to 35 
kg) were sedated with intramuseular ketamine (20 mg/kg) 
and anesthetieally treated with sodium thiopental (15 
mg/kg). Pressure-transducer atheters were placed in the 
inferior vena cava via the femoral rein and the thoraeic 
aorta via the femoral artery to monitor central venous 
pressure and systemic arterial pressures, respectively. 
Crystalloid solutions were administered to maintain cen- 
tral venous pressure at 3 to 8 cm H20 in all animals. 
Throughout he study, arterial blood gas values were 
monitored and appropriate interventions made to keep 
the pH value '7.35 to 7.45, carbon dioxide tension 35 to 45 
torr, and oxygen tension greater than 100 torr. 
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Fig. 1. ]3-Adrenergic receptor complex (see text for de- 
tails). 
After median sternotomy, hearts were instrumented to
measure left ventricular major and minor axis diameters 
with ultrasonic dimension transducers and left ventricular 
pressure with micromanometers. After baseline left ven- 
tricular pressure-volume data were obtained uring tran- 
sient vena caval occlusions and left ventricular t ansmyo- 
cardial biopsy samples obtained, brain death was induced 
(n = 6) by ligation of the innominate trunk and the left 
subclavian artery, which effectively interrupted perfusion 
from the carotid and vertebral systems bilaterally. 1'lo This 
method of producing ischemic brain death has been 
demonstrated in our laboratory to reduce cerebral blood 
flow to less than 5% of control values. A second group of 
pigs (n = 6) was not subjected to brain death and served 
as a control group. Left ventricular pressure-volume data 
and transmyocardial biopsy samples were obtained at 
hourly intervals in all animals. Biopsy specimens were 
obtained in the anatomically identical place in the apex of 
the left ventricle with a 7F biopsy needle, immediately 
frozen in liquid nitrogen, and stored at -70 ° C. Studies in 
our laboratory have confirmed that taking these biopsy 
specimens does not alter ventricular function. Two-di- 
mensional echocardiograms were recorded at each stage 
of the experiment for the determination f left ventricular 
wall volume. At the conclusion of each study the myocar- 
dium was dissected and lefl ventricular wall volume 
confirmed by saline solution displacement. 
Left ventricular function. Left ventricular shell volume 
was calculated from the ultrasonographically determined 
epieardial base-apex (major) and anteroposterior (minor) 
axes with 9 use of a modified ellipsoid shell model. Left 
ventrieular eavitary volume was determined by subtracting 
eehocardiographically derived leit ventricular wall vol- 
urne, by the method described by Feneley and associ- 
11 ates, from the shell volume. Stroke work was ealculated 
as the area of each left ventrieular pressure-volume loop 
and related to end-diästolie volume. Preload-recruitable 
stroke work (PRSW), defined as the slope of the stroke 
work-end-diastolic volume relationship, was used as a 
load-insensitive index of myocardial performance 12 and 
expressed as a fraction of the baseline value (PRSW 
index). 
B-Receptor analysis. Myocardial biopsy samples were 
thawed in ice-cold lysis buffer (Tris 5 mmol/L; ethyl- 
enediaminetetraacetic ac d[EDTA] 2 mmol/L; pH 7.4 at 
4 ° C) and homogenized with a Polytron homogenizer 
(Brinkman Instruments, Westbury, N.Y.) at 75% maximal 
speed for 5 seconds. The lysis buffer, and all subsequent 
buffers described for ligand binding or adenylate cyclase 
assays, contained the protease inhibitor benzamidine (10 
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Table I. Results of analysis of cardiac function before and after brain death 
Baseline 1 hr 2 hr 3 hr 
PRSW index in experimental 1.0 
animals 
PRSW index in control ani- 1.0 
mals (not subjected to 
brain death) 
0.83 -+ 0.14 (p < 0.05) 
0.98 + 0.08 (NS) 
0.90 - 0.08 (p < 0.05) 
0.96 - 0.12 (NS) 
0.62 -+ 0.16 (p < 0.01) 
0.97 -+ 0.10 (NS) 
Values given as mean plus or minus the standard deviation. NS, Not significant. 
~g/ml), soybean trypsin inhibitor (10 t~g/ml), and leupep- 
tin (5 ~g/ml). After homogenization, the particulate sus- 
pension was diluted 15-fold in lysis buffer and centrifuged 
at 20,000 rpm (Sorvall RC-5C centrifuge, Du Pont Com- 
pany, Wilmington, Del.) for 15 minutes at 4 ° C. The pellet 
was resuspended in ice-cold resuspension buffer (Tris 75 
mmol/L, MgC12 5 mmol/L, EDTA 2 mmol/L, pH 7.4) and 
filtered through one layer of 100/zl nylon mesh to remove 
tissue clumps. Resuspension buffer was added to the 
membrane suspension to adjust he final concentration to
10 tzl buffer per milligram tissue wet weight for assay. 
B-Reeeptor radioligand bindlng. Myocardial /3-recep- 
tor density was determined with the use of saturation 
[125I]-iodocyanopindolol (ICYP) binding as previously 
13 described. For saturation binding studies, membranes 
(approximately 10tzg total protein) were incubated with 
saturating concentrations of ICYP (250 pmol/L) in the 
absence (total binding) and presence (nonspecific bind- 
ing) of 1 mmol/L propranolol for 2 hours at 25 ° C. GTP 
(100 ~mol/L) was included in the incubations to eliminate 
any retained agonist binding. The reactions were termi- 
nated by vacuum filtration over glass fiber (GF/C) filters, 
which were subsequently washed three times with ice-cold 
Tris buffer (10 mmol/L). Filters were counted in a gamma 
counter at 70% etficiency. Both receptor densities and 
adenylate cyclase activities were normalized to protein, 
which was measured by the copper-bicinchoninic a id 
methodJ 4Receptor-specific binding was calculated as the 
difference between total and nonspecific binding. 
Adenylate cyelase aetivities. Myocardial adenylate cy- 
clase activity was assessed by the method of Salomon, 
Londos, and Rodbell, 15 as modified and described previ- 
ouslyJ 6 Samples (approximately 20/xg total protein) were 
incubated in glass tubes in triplicate with various reagents 
in a reaction mixture that consisted of Tris 30 mmol/L (pH 
7.4), MgC12 2 mmol/L, EDTA 0.8 mmol/L, ascorbic acid 
0.8 mmol/L to prevent catecholamine oxidation, adeno- 
sine triphosphate (ATP) 0.12 mmol/L, GTP 53.0 ~mol/L, 
phosphoenolpyruvate 2.7 mmol/L, myokinase 1.0 IU, 
pyruvate kinase 0.2 IU, cAMP 0.1 mmol/L, and 50 ~CI/ml 
of [ot-32P] ATP in a final volume of 50/zl for 30 minutes at 
37 ° C. Reactions were stopped by adding 1.0 ml ice-cold 
"stop solution" (200 mg/ml ATP, 100 mg/L cAMP, 25/L1/L 
3H-cAMP) in an ice bath. The final free Mg 2+ concentra- 
tion in these reactions is approximately 1 mmol/L. 
Coupling to adenylate cyclase stimulation was tested at 
the level of the/3-receptor (isoproterenol 100/~mol/L). In 
addition, the function of other components of the/3-re- 
ceptor/adenylate cyclase pathway was tested with the use 
of 10/xmol/L sodium fluoride (direct stimulation of the 
guanine nucleotide, or G protein) and 100 txmol/L fors- 
kolin (direct stimulation of the adenylate cyclase moiety). 
The samples were then spun in a table-top centrifuge for 
2 minutes at 4 ° C at maximum speed to pellet the 
membrane. The supernatant was processed by sequential 
chromatography to isolate [aYp] cAMP produced by the 
reaction. Sequential chromatography was done with 
dowex and alumina columns. Dowex columns were 
washed with deionized water and alumina columns were 
washed with 0.1 mol/L imidazole into scintillation vials. 
Final results were expressed as picomoles cAMP per 
milligram protein per 30 minutes. 
Complete analysis of the/3-receptor comptex included 
determination f/3-receptor density and quantification of
/3-receptor functional capacity by stimulation at three 
distinct points along the /3-receptor signal transduction 
pathway before and hourly after brain death. Compari- 
sons were made with paired two-tailed Student's t tests. A 
p value <0.05 was considered significant. Data are pre- 
sented as mean plus or minus the standard eviation. 
Results 
Left ventricular function. The effect of brain 
death on systolic myocardial performance is demon- 
strated in Table I. Deterioration of myocardial 
performance occurred within the first hour after 
brain death, as illustrated by the significant (p < 
0.05) decrease in the PRSW index. There was no 
further significant change in myocardial perfor- 
mance throughout he duration of the study. In 
control animals, not subjected to brain death, there 
was no significant change in cardiac function 
throughout the time course of the experiment. 
B-Receptor function. The effect of brain death on 
the function of the /3-receptor is summarized in 
Table I I . /3-Receptor density was stable after brain 
death. Isoproterenol-stimulated, sodium fluoride- 
stimulated, and forskolin-stimulated adenylate cy- 
clase activity decreased significantly within the first 
hour after brain death. There was no further signif- 
icant change in adenylate cyclase activity throughout 
the course of the study. When adenylate cyclase 
activity was normalized, the magnitude of the effect 
of brain death on adenylate cyclase stimulation by 
isoproterenol, sodium fluoride, and forskolin was 
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Fig. 2. Adenylate cyclase activity after brain death expressed as percent of baseline. 
Table II. Results of analysis of/3-adrenergic receptor density and activity before and after brain death (as 
compared with baseline values) 
Baseline 1 hr 2 hr 3 hr 
B-Adrenergic: receptor density 
(fmol/mg protein) 
Inoprotereno!-stimulated ade- 
nylate cyclase activity (pmol 
cAMP/mg protein/30 min) 
Sodium fluoride-stimulated a e- 
nylate cyclase activity (pmol 
cAMP/mg protein/30 min) 
Forskolin-stimulated a enylate 
cyclase actMty (pmol cAMP/mg 
protein/30 min) 
50 ± 14 37 ± 14 (NS) 45 ± 8 (NS) 46 ± 12 (NS) 
975 ± 168 475 ± 249(p< 0.01) 417 ± 320(/9<0.001) 425 ± 235(p<0.01) 
7404 2 2240 
10,626 -+ 2508 
4393 ± 2026 (p < 0.05) 
6537 ± 2608 (p < 0.01) 
3346 ± 2860 (p < 0.05) 
4469 ± 4140 (p < 0.05) 
4214 ± 1680 (p < 0.05) 
5680 ± 2144 (p < 0.01) 
Values given as mean plus or minus the standard eviation. NS, Not significant. 
demonstrated to be similar (Fig. 2). In contrast, 
control pigs (not subjected to brain death) demon- 
strated no change in/3-adrenergic receptor density 
or adenylate cyclase activity during the same period 
(Table III). 
Discussion 
Successful transplantation depends on appropri- 
ate treatrnent of potential organ donors. Brain 
death is followed by profound metabolic and car- 
diovascular alterations, 4 increased production of 
catecholamines, 17 calcium overflow injury in the 
myoeardium, 5 and eardiac dysfunction. 1' a The car- 
diovascula~ pathophysiologic process of brain death 
may inhibit ventricular function of a potential car- 
diac allograft and jeopardize the support of other 
organs bef0re retrieval. 
Cellular rnechanisms responsible for development 
of myocardial dysfunction after brain death have not 
been invesfigated. Catecholamine l vels have been 
shown to be uniformly elevated after the induction 
of experim~ntal brain death. 4 In addition, the ad- 
ministration of /3-adrenergic receptor antagonists 
before the induction of cerebral ischemia has been 
shown to prevent he development of myocardial 
injury.7, 8 Thus the myocardial/3-adrenergic re ep- 
tor may be involved in the pathophysiologic process 
of brain death. Therefore the present study was 
designed to investigate the effect of brain death on 
the myocardial/3-receptor with the use of parame- 
ters of receptor density and functional coupling of 
the receptor to the stimulation of adenylate cyclase. 
Deterioration of myocardial performance is ob- 
served within the first hour after brain death. The 
development of cardiac dysfunction is not related to 
B-receptor density, which remained stable over the 
course of the study. However, analysis of the func- 
tional stimulation of the /3-receptor demonstrated 
an inhibitory effect of brain death on adenylate 
cyclase stimulation (cAMP production) at all three 
locations along the signal transduction pathway (/3- 
receptor, G protein, and adenylate cyclase moieß0. 
Because no further decrease in adenylate cyclase 
stimulation is seen at the receptor or G protein 
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Table III. Results of analysis of [3-adrenergic receptor density and activity in control animaIs (not subjected to 
brain death) 
Baseline 1 hr 3 hr 
B-Adrenergic receptor density 
(fmol/mg protein) 
Isoproterenol-stimulated ad nylate 
cyclase activity (pmol cAMP/mg 
protein/30 min) 
Sodium fluoride-stimulated ade- 
nylate cyclase activity (pmol 
cAMP/mg protein/30 min) 
Forskolin-stimulated adenylate 
cyclase activity (pmol cAMP/mg 
protein/30 min) 
34 ± 14 48 ± 16(p= 0.22) 47 ± 21(,o= 0.34) 
310 ± 1121 393 ± 167(,o= 0.20) 351 ~ 136(p= 0.56) 
1267 ± 627 1425± 557(/9= 0.54) 1496 ± 828(/)= 0.54) 
4060 ± 1527 4373 ± 1679 (p = 0.52) 3657 _+ 1133 (p = 0.48) 
Values given as mean plus er minus the standard eviation. 
level, the effect of ischemic brain death on the 
B-adrenergic signal transduction system appears to 
be localized to the adenylate cyclase moiety (the 
final catalytic unit) over the time course studied. 
The lack of changes in /3-receptor density and 
functional coupling in control pigs suggests that 
these results are not simply a result of time, opera- 
tion, or anesthesia, but are specific for brain death. 
Desensitization is a functional definition and re- 
fers to impaired responsiveness to a drug over time. 
Three mechanisms of desensitization are generally 
attributed to G protein-coupled receptors: (1) de- 
creased receptor density secondary to transient re- 
ceptor internalization (sequestration), (2)decreased 
receptor density secondary to internalization fol- 
lowed by destruction of receptors (down-regula- 
tion), and (3) impairment in the coupling of one of 
the functional components of the receptor system. 
In this model of brain death, because receptor 
number emained constant, impairment of coupling 
of /3-receptors to their second messenger system 
appears to be the mechanism ofmyocardial dysfunc- 
tion. Furthermore, this defect is localized to the 
adenylate cyclase moiety. 
Depending on the model of brain death used, 
myocardial ischemia may or may not be present. 
Hence it is important to differentiate he effects of 
brain death per se from associated myocardial isch- 
emia and its inherent effects on /3-receptor func- 
tion) 8 Although myocardial blood flow has been 
demonstrated to decrease in this porcine model of 
brain death, the ratio of endocardial to epicardial 
flow is not affected, t9This suggests that myocardial 
ischemia is not a major component in the patho- 
physiologic process of myocardial dysfunction i our 
model of brain death. Thus this study provides a 
relatively pure environment in which to investigate 
mechanisms of myocardial dysfunction after brain 
death. 
In summary, this study confirms that significant 
dysfunction occurs within 1 hour after induction of 
brain death and is not related to/3-receptor number 
in this porcine model. The pathophysiologic process 
of cardiac dysfunction after brain death may involve 
desensitization f the /3-receptor. Deterioration of 
myocardial performance is temporally related to a 
defect in /3-receptor/G protein/adenylate cyclase 
coupling. This defect appears to be localized to the 
adenylate cyclase moiety itself. Further studies will 
be required to elucidate the exact defect in the 
adenylate cyclase moiety responsible for deteriora- 
tion in myocardial performance after brain death 
and to evaluate therapeutic approaches tothe treat- 
ment of potential organ donors. 
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